The UK is a world leader in advanced therapy development, evaluation and clinical delivery, with the field expected to grow significantly in future. The NHSA has convened a network of experts to ensure the North’s cell and gene therapy excellence is at the forefront of the UK’s global advanced therapy medicinal products (ATMP) strategy.
The Northern Advanced Therapies Network brings together academic, clinical and industry leaders to coordinate activities and share knowledge. The network includes organisations with interests ranging from ATMP discovery and pre-clinical research, through translational development and clinical evaluation, to adoption and spread in the NHS.
By working in partnership across the North, we: improve visibility of the region’s ATMPs strength with policy makers, industry and health leaders; identify and coordinate collaborative funding opportunities and; seek funds to bring state of the art technologies and facilities to the North promoting fast progress of advanced therapies to benefit patients and commercialisation.